Fj. Fenoy et al., EFFECTS OF N-OMEGA-NITRO-L-ARGININE AND N-ACETYL-L-CYSTEINE ON THE REVERSAL OF ONE-KIDNEY, ONE-CLIP HYPERTENSION, American journal of hypertension, 10(11), 1997, pp. 1208-1215
The present study evaluated whether nitric oxide (NO) synthesis blocka
de or potentiation (with N-omega-nitro-L-arginine or N-acetyl-L-cystei
ne, respectively) modulates the systemic and renal responses to unclip
ping in anesthetized one-kidney, one-clip hypertensive rats (1K-1C). C
ardiac output was measured by thermodilution. In time-control rats, me
an arterial pressure (MAP) decreased from 197 +/- 8 mm Hg to 139 +/- 4
mm Hg 3 h after unclipping, and cardiac index (CI) decreased by 35%,
with a transient rise in sodium and water excretion and no changes in
total peripheral resistance (TPR), glomerular filtration rate (GFR), o
r renal plasma now (RPF). Administration of N-omega-nitro-L-arginine m
ethyl ester (NAME, 10 mu g/kg/min) blunted the hypotensive (from 190 /- 6 mm Hg to 157 +/- 3 mm Hg), diuretic and natriuretic responses and
potentiated the decrease in CI (40%) observed after unclipping, where
as TPR increased by 103%. Also, in rats given NAME, GFR and RPF decrea
sed by 20% and 45%, respectively, at the end of the experiment. The ef
fect of N-acetyl-L-cysteine (NAG, 300 mg/kg), a sulfhydryl group donor
that may protect NO from free radical destruction by forming an S-nit
rosothiol compound, was also evaluated. NAC potentiated the depressor
response to unclipping (from 180 +/- 5 mm Hg to 97 +/- 3 mm Hg), and G
FR and RPF increased by 80% and 35%, respectively. These effects of NA
C appear to be NO dependent, as they were blocked by simultaneous admi
nistration of NAME. However, no significant differences were observed
among groups in cumulative excretion of sodium and water, demonstratin
g that the hemodynamic effects of NAME and NAC after unclipping are du
e to mechanisms other than renal excretory changes. The results of the
present study indicate that the cardiovascular depressor effects of u
nclipping are modulated by endothelium-derived nitric oxide. (C) 1997
American Journal of Hypertension, Ltd.